People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biolinq Inc | — | Biotechnology | Series C | $247.4M | $618.5M | 2016 |
Jared Tangney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jared Tangney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Bradbury | 1 | 7 |
| Nancy Hong | 1 | 4 |
| Zina Affas Besse | 1 | 4 |
| Dan Bradbury | 1 | 3 |
| CHRIS DIMITROPOULOS | 1 | 3 |
| Lana Ghanem | 1 | 2 |
| RICHARD YANG | 1 | 2 |
| Joshua Windmiller | 1 | 1 |
| THAD JOHNSON | 1 | 1 |
| JARED AFFAS TANGNEY | 1 | 1 |
| DAVID AFFAS ARIDA | 1 | 1 |
| DAVID ARIDA | 1 | 1 |
| DAVID AFFAS BERRY | 1 | 1 |
| Edward Kliphuis | 1 | 1 |
| DEREK RAPP | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.